Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598143 · ClinicalTrials.gov registry record
Biomarkers of Molecular Risk in Smokers
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 45
- Enrollment target
NCT00598143: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00598143 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598143 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Doctors at MSKCC are doing this research study to see if smokers are interested in the idea that genes might be markers of cancer risk, and to see if smokers would want to learn this information about their risk if it were available. Different versions of the gene called UGT1A7 are found in different people. Certain versions of this gene can increase the risk of cancer in people. In this study, doctors will determine the different types of UGT1A7 in smokers and find out whether smokers show good interest and understanding. The information from this study will be used in future studies to identify smokers at increased risk for cancer, and to help smokers quit.
Interventions
- BEHAVIORAL Vignette, questionnaires and Saliva Samples
- BEHAVIORAL Urine Collection, Smoking cessation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-02 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598143
The ClinicalTrials.gov registry entry for NCT00598143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vignette, questionnaires and Saliva Samples is the first listed.
NCT00598143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00598143 about?
NCT00598143 is a clinical study titled "Biomarkers of Molecular Risk in Smokers". Doctors at MSKCC are doing this research study to see if smokers are interested in the idea that genes might be markers of cancer risk, and to see if smokers would want to learn this information about their risk if it were available. Different versions of the gene called UGT1A7 are found in differe...
What is the current status of trial NCT00598143?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2005-02. Estimated completion is 2015-05.
What interventions are being tested in trial NCT00598143?
The interventions under investigation include: Vignette, questionnaires and Saliva Samples (BEHAVIORAL), Urine Collection, Smoking cessation treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00598143?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.